N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 462-467

  Nerelius, Charlotte ^a   Alvelius, Gunvor ^a   Jörnvall, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Diabetes type 1 and 2; Peptide deposits; Proinsulin C peptide; Protein aggregation; Protein interactions

Indexed keywords

C PEPTIDE; GLUTAMIC ACID; INSULIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CONTROLLED STUDY; INSULIN DEGRADATION; INSULIN RELEASE; INSULIN SYNTHESIS; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUTAMIC ACID; HUMANS; INSULIN; MOLECULAR SEQUENCE DATA;

EID: 78650168784     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.058     Document Type: Article

References (37)

1. Johansson B.L., Sjoberg S., Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992, 35:121-128.
2. Sjoquist M., Huang W., Johansson B.L. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int. 1998, 54:758-764.
3. Wahren J., Ekberg K., Jornvall H. C-peptide is a bioactive peptide. Diabetologia 2007, 50:503-509.
4. Johansson B.L., Borg K., Fernqvist-Forbes E., Kernell A., Odergren T., Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus. Diab. Med. 2000, 17:181-189.
5. Hills C.E., Brunskill N.J. Cellular and physiological effects of C-peptide. Clin. Sci. (Lond) 2009, 116:565-574.
6. Clark J.L., Cho S., Rubenstein A.H., Steiner D.F. Isolation of a proinsulin connecting peptide fragment (C-peptide) from bovine and human pancreas. Biochem. Biophys. Res. Commun. 1969, 35:456-461.
7. Steiner D.F., Clark J.L., Nolan C., Rubenstein A.H., Margoliash E., Aten B., Oyer P.E. Proinsulin and the biosynthesis of insulin. Recent Prog. Horm. Res. 1969, 25:207-282.
8. Steiner D.F., Cunningham D., Spigelman L., Aten B. Insulin biosynthesis: evidence for a precursor. Science 1967, 157:697-700.
9. Steiner D.F., Oyer P.E. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc. Natl. Acad. Sci. USA 1967, 57:473-480.
10. Dunn M.F. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer - a review. Biometals 2005, 18:295-303.
11. Ekberg K., Brismar T., Johansson B.L., Lindstrom P., Juntti-Berggren L., Norrby A., Berne C., Arnqvist H.J., Bolinder J., Wahren J. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diab. Care 2007, 30:71-76.
12. Zerbini G., Mangili R., Luzi L. Higher post-absorptive C-peptide levels in type 1 diabetic patients without renal complications. Diab. Med. 1999, 16:1048.
13. Sjoberg S., Gunnarsson R., Gjotterberg M., Lefvert A.K., Persson A., Ostman J. Residual insulin production, glycaemic control and prevalence of microvascular lesions and polyneuropathy in long-term type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987, 30:208-213.
14. Rigler R., Pramanik A., Jonasson P., Kratz G., Jansson O.T., Nygren P., Stahl S., Ekberg K., Johansson B., Uhlen S., Uhlen M., Jornvall H., Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. USA 1999, 96:13318-13323.
15. +-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol. Life Sci. 2004, 61:2782-2790.
16. +-ATPase activity in diabetes mellitus type I. Clin. Sci. (Lond) 2000, 98:283-290.
17. Wallerath T., Kunt T., Forst T., Closs E.I., Lehmann R., Flohr T., Gabriel M., Schafer D., Gopfert A., Pfutzner A., Beyer J., Forstermann U. Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 2003, 9:95-102.
18. +-ATPase activity of renal tubule segments. Diabetologia 1998, 41:287-291.
19. Pramanik A., Ekberg K., Zhong Z., Shafqat J., Henriksson M., Jansson O., Tibell A., Tally M., Wahren J., Jornvall H., Rigler R., Johansson J. C-peptide binding to human cell membranes: importance of Glu27. Biochem. Biophys. Res. Commun. 2001, 284:94-98.
20. Luppi P., Geng X., Cifarelli V., Drain P., Trucco M. C-peptide is internalised in human endothelial and vascular smooth muscle cells via early endosomes. Diabetologia 2009, 52:2218-2228.
21. Lindahl E., Nyman U., Melles E., Sigmundsson K., Stahlberg M., Wahren J., Obrink B., Shafqat J., Joseph B., Jornvall H. Cellular internalization of proinsulin C-peptide. Cell Mol. Life Sci. 2007, 64:479-486.
22. Lindahl E., Nyman U., Zaman F., Palmberg C., Cascante A., Shafqat J., Takigawa M., Savendahl L., Jornvall H., Joseph B. Proinsulin C-peptide regulates ribosomal RNA expression. J. Biol. Chem. 2010, 285:3462-3469.
23. Jornvall H., Lindahl E., Astorga-Wells J., Lind J., Holmlund A., Melles E., Alvelius G., Nerelius C., Maler L., Johansson J. Oligomerization and insulin interactions of proinsulin C-peptide: Threefold relationships to properties of insulin. Biochem. Biophys. Res. Commun. 2010, 391:1561-1566.
24. Shafqat J., Melles E., Sigmundsson K., Johansson B.L., Ekberg K., Alvelius G., Henriksson M., Johansson J., Wahren J., Jornvall H. Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol. Life Sci. 2006, 63:1805-1811.
25. Lind J., Lindahl E., Peralvarez-Marin A., Holmlund A., Jornvall H., Maler L. Structural features of proinsulin C-peptide oligomeric and amyloid states. FEBS J. 2010, 277:3759-3768.
26. Sudmeier J.L., Bell S.J., Storm M.C., Dunn M.F. Cadmium-113 nuclear magnetic resonance studies of bovine insulin: two-zinc insulin hexamer specifically binds calcium. Science 1981, 212:560-562.
27. Howell S.L., Tyhurst M., Duvefelt H., Andersson A., Hellerstrom C. Role of zinc and calcium in the formation and storage of insulin in the pancreatic beta-cell. Cell Tissue Res. 1978, 188:107-118.
28. Howell S.L., Montague W., Tyhurst M. Calcium distribution in islets of Langerhans: a study of calcium concentrations and of calcium accumulation in B cell organelles. J. Cell Sci. 1975, 19:395-409.
29. Dodson G., Steiner D. The role of assembly in insulin's biosynthesis. Curr. Opin. Struct. Biol. 1998, 8:189-194.
30. Dische F.E., Wernstedt C., Westermark G.T., Westermark P., Pepys M.B., Rennie J.A., Gilbey S.G., Watkins P.J. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 1988, 31:158-161.
31. Furuta T., Seino J., Saito T., Sato H., Agatsuma J., Ootaka T., Satoh T., Yoshinaga K. Insulin deposits in membranous nephropathy associated with diabetes mellitus. Clin. Nephrol. 1992, 37:65-69.
32. Chen L.M., Yang X.W., Tang J.G. Acidic residues on the N-terminus of proinsulin C-peptide are important for the folding of insulin precursor. J. Biochem. 2002, 131:855-859.
33. Brange J., Andersen L., Laursen E.D., Meyn G., Rasmussen E. Toward understanding insulin fibrillation. J. Pharm. Sci. 1997, 86:517-525.
34. Marx N., Walcher D., Raichle C., Aleksic M., Bach H., Grub M., Hombach V., Libby P., Zieske A., Homma S., Strong J. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 2004, 24:540-545.
35. Nerelius C., Martin E., Peng S., Gustafsson M., Nordling K., Weaver T., Johansson J. Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C. Biochem. J. 2008, 416:201-209.
36. Fitzen M., Alvelius G., Nordling K., Jornvall H., Bergman T., Johansson J. Peptide-binding specificity of the prosurfactant protein C Brichos domain analyzed by electrospray ionization mass spectrometry. Rapid. Commun. Mass Spectrom. 2009, 23:3591-3598.
37. Johansson H., Nordling K., Weaver T.E., Johansson J. The Brichos domain-containing C-terminal part of pro-surfactant protein C binds to an unfolded poly-val transmembrane segment. J. Biol. Chem. 2006, 281:21032-21039.